Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 381637Generated: October 31, 2026

2-Bromopropane → (2S,7S)-7-(4-fluorophenoxymethyl)-2-(4-tetrahydropyranoyl-1-butynyl)oxepane

https://huagongshe.com/reaction/381637

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-BromopropaneHCID 6358—
Reactant1,2-DibromoethaneHCID 7839—
ReactantMagnesiumHCID 5462224—
Reactant(2RS,7S)-2-(benzenesulfonyl)-7-(4-fluorophenoxymethyl)oxepaneHCID 70026601—
Reactant4-Tetrahydropyranoyl-1-butyneHCID 86584815—
CatalystZinc bromideHCID 10421208—
SolventTetrahydrofuranHCID 8028—
Product(2S,7S)-7-(4-fluorophenoxymethyl)-2-(4-tetrahydropyranoyl-1-butynyl)oxepaneHCID 70026044—

Reaction Steps

To a suspension of magnesium (0.58 g, 24.2 mmol) in dry THF (10 ml) was added catalytic 1,2-dibromoethane followed by dropwise addition of a soluton of isopropyl bromide (1.85 g, 15.1 mmol) in THF (5 ml). The reaction mixture was stirred for 1 hour and isoprpylmagnesiumbromide was cannulated into a 50 ml two-necked flask. A solution of 4-tetrahydropyranoyl-1-butyne (1.86 g, 12.0 mmol) in THF (5 ml) was added and the mixture was stirred for 30 minutes followed by addition of freshly prepared ZnBr2 solution (1 M, 7.25 ml, 7.2 mmol) in THF at 0° . After 45 minutes (2RS,7S)-2-(benzenesulfonyl)-7-(4-fluorophenoxymethyl)oxepane (2.2 g, 6.0 mmol) in THF (10 ml) was added and the mixture stirred for 30 hours. The reaction was quenched with saturated aqueous NH4Cl solution at 0° C. THF was removed under reduced preesure and the residue was portioned between EtOAc and water. The organic layer was washed with a brine, dried over Na2SO4 and concentrated to give (2S,7S)-7-(4-fluorophenoxymethyl)-2-(4-tetrahydropyranoyl-1-butynyl)oxepane. The crude product was dissolved in MeOH (25 ml) and 1% HCl in MeOH (5ml) was added. The hydrolysis of the THF group was completed in 2 hours and neutralized with saturated Na2CO3 solution and concentrated. The crude product was purified by silica gel chromatography using EtOAc-hexane (1:8) to give (2S,7S)-7-(4-fluorophenoxymethyl)-2-(4-hydroxybutynyl)oxepane (1.32 g, 75%); [α]D−74 (c 3.63, CHCl3), 1H-NMR (CDCl3, 200 Hz): δ 1.4-2.0 (m, 7H), 2.12 (m, 1H), 2.3 (s, 1H), 2.46 (dt, 2H), 3.65 (t, J=3.6 Hz, 2H), 3.74-3.97 (m, 2H), 4.51 (q, 1H), 6.8-7.0 (m, 4H); HRMS (EI): calcd. for C17H21O3F (M+) 292.147756 found 292.147473. Also, (2S,7S)-7-(4-fluorophenoxymethyl)-2-(4-hydroxybutynyl)oxepane by similar procedure: [α]D+26.9 (c 2.2, CHCl3), 1H-NMR (CDCl3, 200 Hz): δ 1.48-2.03 (m, 8H), 2.2 (s, 1H), 2.47 (dt, 2H), 3.69 (t, J=6.9 Hz, 2H), 3.74-4.02 (m, 3H), 4.34 (dt, 2H), 6.78-7.0 (m, 4H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06306895B1
Source datasetuspto-grants-2001_10
ORD IDord-31a4ee0f1c7a4e8e802603569d5b3389
Source noteuspto-grants-2001_10